New Hydratherma Naturals Healthy Hair Care line aims to balance moisture, protein in hair
ATLANTA — Healthy Hair Journey Enterprises has introduced the Hydratherma Naturals Healthy Hair Care Collection, a line of natural-based products developed to improve, enhance and maintain healthy hair.
According to the company, it is possible for hair to be over-moisturized, generating protein deficient hair that is weak and limp and unable to hold a curl. On the other hand, hair that has too much protein and is moisture deficient will appear dry and brittle and break easily. The combination of protein and moisture and the synergy of these two agents is the key to healthy hair and natural hair growth and the secret behind how Hydratherma Naturals products deliver on its promise of length retention and beautiful, frizz-free natural curls.
Saleemah Cartwright, a registered nurse and licensed cosmetologist by trade, noticed while working on her clients’ hair that when the hair was well-balanced, the hair would flourish. Too much moisture or protein would result in breakage. Many of her clients, however, did not know how to achieve this balance.
"I tried many products on my hair and the hair of my clients. Most products would result in too much moisture or protein overload in the hair. So after several years of combining many of the hair care ingredients that I absolutely loved, I was able to design a natural-based hair care collection that provides the perfect balance of moisture and protein levels. I wanted to create an effective solution and a simple hair care regimen that my clients could easily follow," stated Cartwright, creator of Hydratherma Naturals and co-founder of Healthy Hair Journey Enterprises.
Keryx Biopharmaceuticals announces NDA for hyperphosphatemia treatment in chronic kidney disease patients
NEW YORK — Keryx Biopharmaceuticals, Inc., today announced the submission of a new drug application to the U.S. Food and Drug Administration seeking approval for the marketing and sale of Zerenex (ferric citrate coordination complex), the company’s drug candidate for the treatment of elevated serum phosphorus levels, or hyperphosphatemia, in patients with chronic kidney disease on dialysis. The company’s NDA submission is based primarily on the data sets derived from its Phase 3 registration program, which was conducted pursuant to a Special Protocol Assessment agreement with the FDA, and is also supported by efficacy and safety data from several additional studies, including four Phase 3 studies conducted in Japan in CKD patients on dialysis.
"The submission of the Zerenex NDA marks a major milestone for the Company. With approximately 1,500 patients exposed to the drug in the clinical development programs conducted by us and our Japanese partner, JT/Torii, we believe that Zerenex is a safe, effective and highly-differentiated drug candidate and today’s submission brings us one step closer to potentially bringing this drug to patients who can benefit from it," said Ron Bentsue the company’s CEO. "We are grateful to Dr. Julia Lewis, the Study Chair for the Zerenex Phase 3 program, and to our highly skilled internal team of clinical, manufacturing and regulatory professionals, for the time and effort they have dedicated towards this tremendous achievement," continued Bentsur.
The company also plans to submit a Marketing Authorization Application to the European Medicines Agency for regulatory approval of Zerenex in the European Union.
Keryx holds a worldwide license (except for certain Asian Pacific countries) to Zerenex from Panion & BF Biotech, Inc. The Japanese rights are sublicensed by Keryx to Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. On January 7, 2013, JT announced the filing of its NDA with the Japanese Ministry of Health, Labour and Welfare for marketing approval of ferric citrate in Japan for the treatment of hyperphosphatemia in patients with CKD.
Zerenex is also in Phase 2 development in the U.S. for the management of phosphorus and iron deficiency in anemic patients with Stage 3 to 5 non-dialysis dependent CKD.
CVS Caremark’s Accordant Health Services launches new website
WOONSOCKET, R.I. — CVS Caremark has announced that Accordant Health Services has launched an updated website and member portal, which provides new features and services for program members and helps support and improve member engagement and participation for clients.
Accordant.com now provides eligible members with online access to educational materials, videos, communication tools and community resources that encompass 17 conditions such as rheumatoid arthritis, multiple sclerosis, Crohn’s disease and sickle cell disease. In addition, Accordant.com is now integrated with the Accordant Care Management System, which enables personalized and secure on-line communication between Accordant nurses and program members.
The new Accordant.com features offer members the option to choose how, when and where they access the Accordant program. New features include:
- "Let us Know" box on the home page of the website where members can submit questions about their health and their treatment regimen;
- New message center where members receive private messages filled with tips and tools for managing their condition;
- New content where members can find articles, tools and brochures to keep them up-to-date on the latest health information related to their condition; and
- Through the portal, members also can share health information with clinical team members and exchange secure messages with Accordant clinicians at times that are most convenient for them.
"The launch of our member portal marks an important milestone for Accordant," stated Trip Hofer, president of Accordant Health Services. "While most health management organizations position online tools and services as distinct and separate from those provided on the telephone or via mail, we recognize that health care doesn’t happen at a single point in time or through only one channel. The updated member portal at Accordant.com offers a digital experience that further enables Accordant to proactively support and empower individuals with rare conditions to improve their total health and manage their multiple and complex needs."
Access to Accordant.com is included with enrollment in the program. Ongoing enhancements to the website are planned throughout 2013 and 2014, and include expanded health assessments, call scheduling capabilities, online chat with Accordant nurses and advanced educational curricula.